Provided by Tiger Trade Technology Pte. Ltd.

Rani Therapeutics Holdings

1.22
+0.120010.91%
Post-market: 1.19-0.0300-2.46%19:35 EST
Volume:971.29K
Turnover:1.16M
Market Cap:148.24M
PE:-1.61
High:1.27
Open:1.12
Low:1.11
Close:1.10
52wk High:3.87
52wk Low:0.3870
Shares:121.51M
Float Shares:66.89M
Volume Ratio:0.83
T/O Rate:1.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7588
EPS(LYR):-1.0541
ROE:-1187.52%
ROA:-95.52%
PB:-18.86
PE(LYR):-1.16

Loading ...

Insider Buyers At Rani Therapeutics Holdings Sitting On US$1.3m Profit

Simply Wall St.
·
Jan 31

Rani Therapeutics Promotes Alireza Javadi to Chief Technical Officer

Reuters
·
Jan 28

Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.d. to Chief Technical Officer

THOMSON REUTERS
·
Jan 28

Rani Therapeutics Unveils Oral Biologics Platform Targeting Injection-Free Treatments

Reuters
·
Jan 28

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cartesian Therapeutics (RNAC), Rani Therapeutics Holdings (RANI) and Haemonetics (HAE)

TIPRANKS
·
Jan 10

H.C. Wainwright Sticks to Their Buy Rating for Rani Therapeutics Holdings (RANI)

TIPRANKS
·
Jan 09

Rani Therapeutics Launches Phase 1 Trial of Oral GLP-1/GLP-2 Agonist for Obesity Treatment

Reuters
·
Jan 08

Rani Therapeutics Initiates Phase 1 Study of Rt-114 Ranipill® for the Treatment of Obesity in Collaboration With Progen

THOMSON REUTERS
·
Jan 08

Rani Therapeutics Amends Certificate of Incorporation

Reuters
·
Dec 06, 2025

Rani Therapeutics Holdings Amends Certificate of Incorporation

Reuters
·
Nov 26, 2025

H.C. Wainwright Sticks to Its Buy Rating for Rani Therapeutics Holdings (RANI)

TIPRANKS
·
Nov 07, 2025

Rani Therapeutics Reports Financial Challenges Amid Innovation

TIPRANKS
·
Nov 07, 2025

Rani Therapeutics Holdings posts net loss of $31.9 million for Q3 2025

Reuters
·
Nov 07, 2025

Rani Therapeutics Appoints Abraham Bassan and Vasudev Bailey to Board

Reuters
·
Nov 07, 2025

Rani Therapeutics Holdings Inc - Announces $1.085 Bln Collaboration With Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics

THOMSON REUTERS
·
Nov 07, 2025

Rani Therapeutics Holdings Inc - Expects Cash Runway to Extend Into 2028

THOMSON REUTERS
·
Nov 07, 2025

Press Release: Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update

Dow Jones
·
Nov 07, 2025

Stocks to Watch: Getty Images, Rani Therapeutics, Middlesex Water

Dow Jones
·
Nov 01, 2025

Rani Therapeutics Holdings Inc. Files Initial Statement of Beneficial Ownership for Director Vasudev Jaiprakash Bailey

Reuters
·
Oct 31, 2025

Director Makes Bold Move with Massive Stock Purchase in Rani Therapeutics!

TIPRANKS
·
Oct 28, 2025